| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the College of Medicine (DNK) and Department of Medical Biostatistics (RMS), University of Vermont, Burlington, Vermont.
Correspondence: Address correspondence and reprint requests to: David N. Krag, MD, FACS, S. D. Ireland Professor of Surgical Oncology, College of Medicine, University of Vermont, Given Building, Room E309, Burlington, VT 05405; Fax: 802-656-5833; E-mail: david.krag{at}uvm.edu
Background: Results from randomized trials indicate a 5.4% survival advantage associated with axillary dissection. To gain insight on survival outcomes when less than an axillary dissection is performed, we performed a retrospective analysis to determine survival outcome for node-negative and node-positive breast cancer patients when a variable number of nodes were excised.
Methods: The data analyzed in this paper are from the Surveillance, Epidemiology, and End Results (SEER) database, from which 72,102 patients were selected whose breast cancer had been diagnosed in 1988 or later and who were aged 40–79 years at diagnosis, had a single primary lesion, and had 0 to 3 positive lymph nodes. Cases were separated into age groups (40 to 49 and 50 to 79 years), and node-negative cases were separated from those with one to three positive nodes.
Results: This analysis indicates that even when all regional lymph nodes are pathologically negative, the number of nodes removed is associated with survival. In the group of breast cancer patients who had one to three pathologically positive nodes, as with the node-negative group, the higher the number of nodes removed, the greater the survival. The hazard rate for death in the node-negative group was roughly 5% less for each additional five nodes removed. For the node-positive group, the hazard rate for death was between 8% and 9% less for each additional five nodes removed.
Conclusions: This retrospective study supports the notion that removal of regional nodes, even when such nodes are interpreted as pathologically negative, is important for the long-term survival of breast cancer patients.
Key Words: Axilla • Breast cancer • Lymph nodes • Survival
This article has been cited by other articles:
 |
|
 |
|
  L. Verleye, I. Vergote, N. Reed, and P. B. Ottevanger Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer--Gynecological Cancer Group (EORTC-GCG) Ann. Onc., June 25, 2009; (2009) mdp196v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Dabakuyo, F. Bonnetain, P. Roignot, M.-L. Poillot, G. Chaplain, T. Altwegg, G. Hedelin, and P. Arveux Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival Ann. Onc., February 1, 2008; 19(2): 276 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Blancas, J. Garcia-Puche, B Bermejo, E. Hanrahan, C Monteagudo, A Martinez-Agullo, R Rouzier, B. Hennessy, V Valero, and A Lluch Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor Ann. Onc., November 1, 2006; 17(11): 1644 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Escobar, R. J. Patrick, L. A. Rybicki, D. Hicks, D. E. Weng, and J. P. Crowe Prognostic Significance of Residual Breast Disease and Axillary Node Involvement for Patients Who Had Primary Induction Chemotherapy for Advanced Breast Cancer Ann. Surg. Oncol., June 1, 2006; 13(6): 783 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Anderson How Many Nodes Are Enough? The Breast Surgeon's Dilemma Ann. Surg. Oncol., April 1, 2006; 13(4): 439 - 441. [Full Text] [PDF]
|
|
|
|
|
|
M. Schaapveld, E. G. E. de Vries, W. T. A. van der Graaf, R. Otter, J. de Vries, and P. H. B. Willemse The Prognostic Effect of the Number of Histologically Examined Axillary Lymph Nodes in Breast Cancer: Stage Migration or Age Association? Ann. Surg. Oncol., April 1, 2006; 13(4): 465 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Ludwig, M. Goodman, D. L. Miller, and P. A. S. Johnstone Postoperative Survival and the Number of Lymph Nodes Sampled During Resection of Node-Negative Non-Small Cell Lung Cancer Chest, September 1, 2005; 128(3): 1545 - 1550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rouzier and G. N. Hortobagyi The Removal of Regional Nodes Even When "Pathologically Negative" for Long-term Survival Should be Discussed Cautiously Ann. Surg. Oncol., September 1, 2004; 11(9): 879 - 880. [Full Text] [PDF]
|
|
|
|
|
|
K. M. McMasters The Eternally Enigmatic Axilla: Further Controversy About Axillary Lymph Nodes in Breast Cancer Ann. Surg. Oncol., December 1, 2003; 10(10): 1128 - 1130. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
